These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 24381140)

  • 1. Association of ITGA3 gene polymorphisms with susceptibility and clinicopathological characteristics of osteosarcoma.
    Yang W; He M; Zhao J; Wang Z
    Med Oncol; 2014 Feb; 31(2):826. PubMed ID: 24381140
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetic variations in interleukin-6 polymorphism and the association with susceptibility and overall survival of osteosarcoma.
    Qi Y; Zhao C; Li H; Zhang B; Tada K; Abe H; Tada M
    Tumour Biol; 2016 Jul; 37(7):9807-11. PubMed ID: 26810186
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Single nucleotide polymorphism of hsa-miR-124a affects risk and prognosis of osteosarcoma.
    Shi ZW; Wang JL; Zhao N; Guan Y; He W
    Cancer Biomark; 2016 Jun; 17(2):249-57. PubMed ID: 27540978
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of GRM4 gene polymorphisms with susceptibility and clinicopathological characteristics of osteosarcoma in Guangxi Chinese population.
    Wang K; Zhao J; He M; Fowdur M; Jiang T; Luo S
    Tumour Biol; 2016 Jan; 37(1):1105-12. PubMed ID: 26276359
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interleukin 10 gene -1082A/G polymorphism is associated with osteosarcoma risk and poor outcomes in the Chinese population.
    Cui Y; Zhu JJ; Ma CB; Cui K; Wang F; Ni SH; Zhang ZY
    Tumour Biol; 2016 Apr; 37(4):4517-22. PubMed ID: 26503210
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Single nucleotide polymorphisms in the NER pathway and clinical outcome of patients with bone malignant tumors.
    Sun XH; Hou WG; Zhao HX; Zhao YL; Ma C; Liu Y
    Asian Pac J Cancer Prev; 2013; 14(3):2049-52. PubMed ID: 23679317
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Polymorphisms in TP53 are associated with risk and survival of osteosarcoma in a Chinese population.
    Ru JY; Cong Y; Kang WB; Yu L; Guo T; Zhao JN
    Int J Clin Exp Pathol; 2015; 8(3):3198-203. PubMed ID: 26045840
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Correlation between TGF-β1 gene 29 T > C single nucleotide polymorphism and clinicopathological characteristics of osteosarcoma.
    Wu Y; Zhao J; He M
    Tumour Biol; 2015 Jul; 36(7):5149-56. PubMed ID: 25663491
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PIK3CA and AKT gene polymorphisms in susceptibility to osteosarcoma in a Chinese population.
    He ML; Wu Y; Zhao JM; Wang Z; Chen YB
    Asian Pac J Cancer Prev; 2013; 14(9):5117-22. PubMed ID: 24175786
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association between CTLA-4 genetic polymorphisms and susceptibility to osteosarcoma in Chinese Han population.
    He J; Wang J; Wang D; Dai S; Yv T; Chen P; Ma R; Diao C; Lv G
    Endocrine; 2014 Mar; 45(2):325-30. PubMed ID: 24078408
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Downregulation of miR-22 acts as an unfavorable prognostic biomarker in osteosarcoma.
    Wang G; Shen N; Cheng L; Lin J; Li K
    Tumour Biol; 2015 Sep; 36(10):7891-5. PubMed ID: 25953260
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predictive potential of glutathione S-transferase polymorphisms for prognosis of osteosarcoma patients on chemotherapy.
    Zhang SL; Mao NF; Sun JY; Shi ZC; Wang B; Sun YJ
    Asian Pac J Cancer Prev; 2012; 13(6):2705-9. PubMed ID: 22938445
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predictive impact of common variations in DNA repair genes on clinical outcome of osteosarcoma.
    Bai SB; Chen HX; Bao YX; Luo X; Zhong JJ
    Asian Pac J Cancer Prev; 2013; 14(6):3677-80. PubMed ID: 23886164
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association between H19 polymorphisms and osteosarcoma risk.
    He TD; Xu D; Sui T; Zhu JK; Wei ZX; Wang YM
    Eur Rev Med Pharmacol Sci; 2017 Oct; 21(17):3775-3780. PubMed ID: 28975992
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tissue microRNA-126 expression level predicts outcome in human osteosarcoma.
    Liu W; Zhao ZY; Shi L; Yuan WD
    Diagn Pathol; 2015 Jul; 10():116. PubMed ID: 26194657
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetic polymorphisms of interleukin-1 beta and osteosarcoma risk.
    He Y; Liang X; Meng C; Shao Z; Gao Y; Wu Q; Liu J; Wang H; Yang S
    Int Orthop; 2014 Aug; 38(8):1671-6. PubMed ID: 24878968
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Candidate germline polymorphisms of genes belonging to the pathways of four drugs used in osteosarcoma standard chemotherapy associated with risk, survival and toxicity in non-metastatic high-grade osteosarcoma.
    Hattinger CM; Biason P; Iacoboni E; Gagno S; Fanelli M; Tavanti E; Vella S; Ferrari S; Roli A; Roncato R; Giodini L; Scotlandi K; Picci P; Toffoli G; Serra M
    Oncotarget; 2016 Sep; 7(38):61970-61987. PubMed ID: 27566557
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic Variant of
    Xu L; Ni J; Wang Y; Dong Y; Wang S
    Technol Cancer Res Treat; 2019 Jan; 18():1533033819874802. PubMed ID: 31522615
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Associations of polymorphisms in the bone morphogenetic protein-2 gene with risk and prognosis of osteosarcoma in a Chinese population.
    Cong Y; Li CJ; Zhao JN; Liu XZ; Shi X
    Tumour Biol; 2015 Mar; 36(3):2059-64. PubMed ID: 25391427
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetic polymorphisms in COL18A1 influence the development of osteosarcoma.
    Guo Z; Zhang T; Wu J; Wang H; Liu X; Tian L
    Int J Clin Exp Pathol; 2015; 8(9):11531-6. PubMed ID: 26617886
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.